NCT03630107

Brief Summary

The aim of the study is to evaluate the tolerance of the Shampoo (WO 5101) on the scalp by a dermatologist and by the subjects themselves after four weeks of regular product use. Additional objective of this clinical in-use study was to evaluate the cosmetic features and the acceptance of the product by means of a questionnaire at the end of the 4-week treatment period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2018

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 14, 2018

Completed
Last Updated

December 19, 2023

Status Verified

December 1, 2023

Enrollment Period

28 days

First QC Date

August 6, 2018

Last Update Submit

December 18, 2023

Conditions

Keywords

itchy scalpchronic pruritus

Outcome Measures

Primary Outcomes (2)

  • Dermatological Tolerance of the Test Product on the Scalp

    Change from Baseline at four weeks by the means of a dermatological assessment of scalp 1. erythema 2. edema 3. dryness 4. scaliness 5. papules 6. pustules 7. fissures 8. pruritus 9. burning 10. Tension all Parameters (a-j) were assessed by 6-tiered rating scale with 0.5 intervals (0=absent; 0.5=very slight, 1/1.5= slight; 2/2.5=moderate; 3/3.5=severe and 4=extreme)

    baseline, four weeks

  • Subjective Tolerance of the Test Product on the Scalp

    Change from baseline at four weeks by means of a self-assessment questionnaire (with 13 questions regarding cosmetic features of the product as well as satisfaction with cosmetic performance).

    baseline, four weeks

Secondary Outcomes (2)

  • Cosmetic Features of the Test Product

    baseline, four weeks

  • Reduction of Pruritus

    baseline, four weeks

Study Arms (1)

WO 5101 Shampoo for Scalp and Hair

EXPERIMENTAL

WO 5101 is used in subjects with chronically itchy scalp

Other: WO 5101 Shampoo for Scalp and Hair

Interventions

Wash the hair at least three times a week for a period of four weeks

WO 5101 Shampoo for Scalp and Hair

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age: ≥ 18 years
  • with chronically itchy scalp
  • normal to dry scalp or scalp prone to neurodermatitis

You may not qualify if:

  • any deviation from the above-mentioned criteria
  • users of sour hair conditioner
  • subjects who wash their hair more than once a day
  • other dermatological disorders (scars, moles) on the scalp
  • known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
  • topical medication in the test area within 1 month prior to study start
  • systemic medication with anti-inflammatory agents and antibiotics within two weeks prior to starting of the study
  • systemic medication with retinoids, antihistamines and/or immunomodulators (e.g. cortisone, corticosterone, chemotherapeutic agents) within four weeks prior to starting of the study
  • severe internistic disease that leads to pruritus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SIT Skin Investigation and Technology Hamburg GmbH

Hamburg, 20354, Germany

Location

Study Officials

  • Kerstin Söhl, MD

    Dermatologist

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2018

First Posted

August 14, 2018

Study Start

February 15, 2018

Primary Completion

March 15, 2018

Study Completion

March 15, 2018

Last Updated

December 19, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations